An APAP machine may help you improve your sleep if you suffer from sleep apnea. Learn the differences between Automatic Positive Airway Pressure machines and if it's best for you.

Savara Introduces aPAP ClearPath™, a GM-CSF Autoantibody Blood Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP) The simple, no-cost, and noninvasive test is now available to ...

Patients’ temperature and symptom scores were monitored for 5–14 days or until time of resolution. They found that acetaminophen was not harmful but it was not found to be beneficial either.

(RTTNews) - Savara Inc. (SVRA), a biopharmaceutical company, Thursday announced that it has introduced the aPAP ClearPath Dried Blood Spot Test in the U.S. This new test builds on its prior serum ...

Savara faces an FDA setback for Molbreevi, its aPAP treatment. Learn how the company plans to recover and file a new BLA by 2025. Click here to read my SVRA analysis.

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, initiated a rolling submiss ...

Women with APAP acute liver failure were more likely to present with severe encephalopathy on admission vs. men (59% vs. 42%; P <0.01) but presence was similar between men and women with non-APAP ...

Savara’s pipeline comprises Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP), in Phase ...